2) in vitro pharmacodynamics
体外药效学
1.
To study the pharmacokinetic and in vitro pharmacodynamics property following single doesing of PEG-rhG-CSF via the route of intramuimular injection in rhesus monkeys and mouse.
通过对杭州九源基因生物工程有限公司开发出的分子量为39kDa的聚乙二醇化重组人粒细胞集落刺激因子(PEG-rhG-CSF)在大鼠和猕猴体内的药代动力学及体外药效学研究,为PEG-rhG-CSF药代动力学及体外药效学提供客观准确的评价,也为其临床研究给药方案的设计和优化提供有力的理论依据。
3) vitro pharmacodynamic model
体外药效学模型
1.
Objective To determine the PK/PD parameters which is more dependent on the inhibition of resistant mutants using vitro pharmacodynamic model.
目的通过体外药效学模型探讨预测抑制细菌耐药突变的PK/PD参数折点。
4) in vitro release
体外释药
1.
Preparation and in vitro release of poly(DL-lactide) microspheres containing tinidazole;
替硝唑聚乳酸微球的制备及其体外释药性能
2.
Study on preparation and in vitro release of 5-fluorouracil loaded polylactide-co-glycolide-co-poly(ethylene glycol) nanoparticles;
PEG-PLGA载5-FU纳米缓释微球的制备及体外释药研究
3.
Formulation optimization and the in vitro release characteristics of Fuyankang Dispersible Tablets;
妇炎康分散片的辅料处方优化及体外释药特性
5) release in vitro
体外释药
1.
Affecting factor of the diclofenac potassium release in vitro from hydroxypopylmethyl cell ulose tablets;
双氯芬酸钾羟丙基甲基纤维素骨架片体外释药的影响因素
2.
Preparation of Nanoliposome Coated with Hydroxycamptothecin and Study on Release in vitro;
羟基喜树碱包衣纳米脂质体的制备及体外释药研究
3.
Preparation of Xionggui nasal sprays and its evaluation in release in vitro and absorption in vivo;
芎归鼻用喷雾剂的制备及其体外释药与在体吸收特性评析
6) In vitro drug release
体外释药
1.
Effects of pH and ionic strength of release media on in vitro drug released from carboxymethyl konjac glucomannan pellets;
释放介质pH和离子强度对羧甲基魔芋胶小丸体外释药的影响
2.
OBJECTIVE To prepare clindamycin hydrochloride microcapsule by means of intra liquid desiccation and to determine its in vitro drug release.
目的 采用液中干燥法制备盐酸克林霉素微囊 ,并考察其体外释药特性。
3.
And factors influencing in vitro drug release rate of the matrix tablets were studied.
以茶碱为模型药物，制备了黄原胶亲水性骨架片，研究了体外释药的影响因素。
补充资料：不成熟卵母细胞体外成熟
不成熟卵母细胞体外成熟
是将表皮生长因子和促性腺激素联合用于不成熟卵母细胞进行体外培养，提高受精率及提高不成熟卵母细胞的体外成熟率。它是一项助孕技术，可以减少超排卵带来的经济负担和卵巢过度刺激的危险。解决卵巢本身缺陷诱发排卵无效病人的生育问题，以及为“卵子指赠”工作提供卵母细胞来源，但体外成熟的卵母细胞的胚胎较体内成熟卵母细胞要差，因此必须了解影响卵母细胞体外成熟能力因素和改善培养环境。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条